Unique ID issued by UMIN | UMIN000034782 |
---|---|
Receipt number | R000039660 |
Scientific Title | Multi-institutional survey of thoracic endovascular aortic repair for patients with esophageal cancer |
Date of disclosure of the study information | 2019/03/31 |
Last modified on | 2020/11/07 10:44:35 |
Multi-institutional survey of thoracic endovascular aortic repair for patients with esophageal cancer
Thoracic endovascular aortic repair for esophageal cancer
Multi-institutional survey of thoracic endovascular aortic repair for patients with esophageal cancer
Thoracic endovascular aortic repair for esophageal cancer
Japan |
Esophageal cancer
Gastrointestinal surgery | Vascular surgery |
Malignancy
NO
To clarify the efficacy of thoracic endovascular aortic repair for esophageal cancer
Efficacy
The survival period after thoracic endovascular aortic repair for bleeding due to esophageal cancer with aortic invasion
The postoperative survival period after esophagectomy following thoracic endovascular aortic repair
Observational
Not applicable |
Not applicable |
Male and Female
Patients who underwent thoracic endovascular aortic repair for esophageal cancer at the authorized institutes for board certificated esophageal surgery between January 2013 and December 2017.
nothing
500
1st name | Masayuki |
Middle name | |
Last name | Masayuki |
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Department of Gastroenterological Surgery
135-8550
3-8-31 Ariake, Koto-ku, Tokyo
0335200111
masayuki.watanabe@jfcr.or.jp
1st name | Masayuki |
Middle name | |
Last name | Watanabe |
Cancer Institute Hospital of Japanese Foundation for Cancer Research
Department of Gastroenterological Surgery
135-8550
3-8-31 Ariake, Koto-ku, Tokyo
0335200111
https://www.jfcr.or.jp/hospital/examination/research/publish.html
masayuki.watanabe@jfcr.or.jp
Japan Esophageal Society
Japan Esophageal Society
Other
Japanese Foundation for Cancer Research
3-8-31 Ariake, Koto-ku, Tokyo
0335200111
med.shinsa@jfcr.or.jp
NO
2019 | Year | 03 | Month | 31 | Day |
https://www.jfcr.or.jp/hospital/examination/research/publish.html
Unpublished
https://link.springer.com/article/10.1007/s10388-019-00683-y
41
The median survival time after TEVAR was 135 days in the hemorrhage or impending hemorrhage group and 378 days in the preoperative prophylaxis group. Eighteen patients underwent esophagectomy after TEVAR. No hemorrhagic event was observed during the perioperative period. The median survival time of the patients who underwent esophagectomy was 373 days.
2020 | Year | 11 | Month | 07 | Day |
The Japan Esophageal Society conducted a questionnaire survey targeting authorized or semi-authorized member institutes of the Authorized Institutes for Board Certified Esophageal Surgeons. Patients who underwent TEVAR for esophageal cancer were identified from 19 institutes.
The Japan Esophageal Society conducted a questionnaire survey targeting authorized or semi-authorized member institutes of the Authorized Institutes for Board Certified Esophageal Surgeons. Patients who underwent TEVAR for esophageal cancer were identified from 19 institutes.
No hemorrhagic event was observed during the perioperative period.
Overall Survival
Preinitiation
2018 | Year | 07 | Month | 31 | Day |
2018 | Year | 11 | Month | 15 | Day |
2019 | Year | 02 | Month | 15 | Day |
The results of thios study have been published in the Esophagus (2020; 17: 74-80).
2018 | Year | 11 | Month | 06 | Day |
2020 | Year | 11 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039660